Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 4/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 4/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.39 |
| ▸ | GRIN2C | Q14957 | 4/20 | 0.39 |
| ▸ | GRIN3A | Q8TCU5 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | SLC22A2 | O15244 | 2/20 | 0.38 |
| ▸ | SLC47A1 | Q96FL8 | 2/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | STAT6 | P42226 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1092580 | 0.81 | GRIN2D (0.39) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL12786209 | 0.75 | GRIN2D (0.35) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL1877773 | 0.73 | GRIN2D (0.42) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL14388724 | 0.73 | GRIN2D (0.33) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL1324015 | 0.71 | — | — | |
| SCHEMBL289384 | 0.69 | GRIN2D (0.35) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL3629491 | 0.69 | GRIN2D (0.35) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL2926239 | 0.69 | GRIN2D (0.35) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL1577736 | 0.69 | GRIN2D (0.35) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL2928546 | 0.69 | SLC22A2 (0.42) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12492281-B2 | Polyisocyanurate materials as electrical potting compounds | COVESTRO DEUTSCHLAND AG (DE) | 2025-12-09 | — | — | US | disclosed |
| CN-113631545-B | Polyisocyanurate materials as electrical potting compounds | 科思创德国股份有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-112204065-B | Process for preparing polyisocyanate polymers and polyisocyanurate plastics | 科思创知识产权两合公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-109642015-B | Method for producing polyisocyanurate plastics by means of phosphine catalysis | 科思创德国股份有限公司 | 2022-09-23 | — | — | CN | disclosed |
| EP-3794049-B1 | METHOD FOR PRODUCING A POLYISOCYANATE POLYMER AND A POLYISOCYANURATE PLASTIC | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-06-08 | — | — | EP | disclosed |
| US-11319402-B2 | Method for producing a polyisocyanate polymer and a polyisocyanurate plastic | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2022-05-03 | — | — | US | disclosed |
| US-20220127407-A1 | POLYISOCYANURATE MATERIALS AS ELECTRICAL POTTING COMPOUNDS | COVESTRO DEUTSCHLAND AG (DE) | 2022-04-28 | — | — | US | disclosed |
| US-11279790-B2 | Process for producing polyisocyanurate plastics by means of phosphine catalysis | COVESTRO DEUTSCHLAND AG (DE) | 2022-03-22 | — | — | US | disclosed |
| EP-3507321-B1 | PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS BY MEANS OF PHOSPHINE CATALYSIS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-03-02 | — | — | EP | disclosed |
| EP-3931185-A1 | POLYISOCYANURATE MATERIALS AS ELECTRICAL POTTING COMPOUNDS | Covestro Intellectual Property GmbH & Co. KG (DE) | 2022-01-05 | — | — | EP | disclosed |
| CN-103502315-A | Composition and polymer | ASAHI KASEI CHEMICALS CORP | 2014-01-08 | — | — | CN | disclosed |
| CN-101289427-B | Preparation of polyisocyanates containing uretdione groups using phosphine catalysts | BAYER MATERIALSCIENCE AG | 2012-06-06 | — | — | CN | disclosed |
| US-20100113255-A1 | NOVEL CARBONYLATION LIGANDS AND THEIR USE IN THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | LUCITE INTERNATIONAL UK LIMITED (GB) | 2010-05-06 | — | — | US | disclosed |
| US-7709680-B2 | Preparation of polyisocyanates containing uretdione groups using phosphine catalysts | BAYER MATERIALSCIENCE AG (DE) | 2010-05-04 | — | — | US | disclosed |
| EP-1982979-B1 | Manufacture of polyisocyanates containing uretdione groups | BAYER MATERIALSCIENCE AG (DE) | 2010-01-27 | — | — | EP | disclosed |
| EP-2097429-A1 | NOVEL CARBONYLATION LIGANDS AND THEIR USE IN THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | Lucite International UK Limited (GB) | 2009-09-09 | — | — | EP | disclosed |
| US-20080262262-A1 | Preparation of polyisocyanates containing uretdione groups using phosphine catalysts | BAYER MATERIALSCIENCE AG | 2008-10-23 | — | — | US | disclosed |
| EP-1982979-A1 | Manufacture of polyisocyanates containing uretdione groups | Bayer MaterialScience AG (DE) | 2008-10-22 | — | — | EP | disclosed |
| CN-101289427-A | Preparation of polyisocyanates containing uretdione groups using phosphine catalysts | BAYER MATERIALSCIENCE AG (DE) | 2008-10-22 | — | — | CN | disclosed |
| WO-2008065448-A1 | NOVEL CARBONYLATION LIGANDS AND THEIR USE IN THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | LUCITE INTERNATIONAL UK LIMITED (GB) | 2008-06-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262262-A1 | Preparation of polyisocyanates containing uretdione groups using phosphine catalysts | PPIP5K2, IPMK, INPP5B | GRIN2D 3596/4885GRIN3B 3405/4885GRIN1 4117/4885 |
| US-20100113255-A1 | NOVEL CARBONYLATION LIGANDS AND THEIR USE IN THE CARBONYLATION OF ETHYLENICALLY UNSATURATED COMPOUNDS | PRDX1, PRDX4, PRDX2 | GRIN2D 3407/4885GRIN3B 4044/4885GRIN1 2797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.